Post Job Free
Sign in

Manager Quality Control

Location:
Alameda, CA
Posted:
January 27, 2013

Contact this candidate

Resume:

Kathy Bailey, Researcher-Resume

K ATHY BAILEY

ACADEMIC BACKGROUND CONTACT KATHY

****, **, ********** ** ************, UCLA *******@********.****.***

****, **, *********, *** ******.pdf

****, ****ytical & Light Microscopy, Woods Hole

1996, Flow Cytometry Laboratory Medicine, UCSF

RESEARCH EXPERIENCE COMPUTER SKILLS

I have conducted experiments and presented findings at meetings in several Computer Networking Certification, San

Francisco City College: UNIX, DOS,

areas of biomedical research: LANs including networking and PCs

Excel

CELL BIOLOGY: I have developed a high throughput assay for detecting PhotoShop

Indesign

unknown anabolic steroids in body fluids; I have developed and performed Dreamweaver

Prism statistical analysis

patient study assays for steroids, lipid transport, scavenger receptors, TGF, Acuity Xpress; MetaMorph; Image

analysis programs for gel, photo-

HTLV I, SK, NK, cytokeratins, oncoproteins; and have cultured and minipulated microscopy and FACS analysis); Perl

programming and Web authoring

primary retinal pigment epithelial cells, rat brain cells, bone marrow cells and

numerous eucaryotic cell lines, including T cells and B cells as required for

ADMINISTRATIVE COURSES

studies. I have prepared and characterized numerous antibodies and used

BIOCHEMISTRY 201 -INTELLECTUAL

them in immuno-histochemical studies and assays; PROPERTY

BIOSTATISTICS 183

GENETICS: I have studied the transforming ability of and performed RFLP MICRO- & MACRO- ECONOMICS

ACCOUNTING

analysis on various oncogenes; have studied the transcriptional regulation of CORPORATE DEVELOPMENT

PAM of EMF: Billing and Reporting

proteins expressed during adrenal medula development; conducted mutational PAM of EMF: Compliance

PAM of EMF: Award Set-Up

analysis of the ara operon; identified specific transposon Tn7 target insertions; PAM of EMF: Award Closeouts and FSRs

RAS Kick Start

and have cloned cDNAs and genomic DNAs of cGMP-gated channels, lectins, RAS Post Award

and oncogenes from lambda and cos libraries and/or pcr.

BIOCHEMISTRY: I have experience in purifications and analysis of proteins

INSTRUMENTATION

and protein modifications (glycosylation and phosphorylation), i.e., collagens, Molecular Devices, IMX High Thruput

lectins, oncoproteins, cytokeratins, monoclonal and polyclonal antibodies to Microscope; FLOW CYTOMETER;

ANALYTICAL AND LIGHT MICROSCOPY;

these proteins. AUTOMATED SEQUENCER, ALF;

OLIGONUCLEOTIDE SYNTHESIZER:

ADMINISTRATIVE EXPERIENCE Protocols and chemistries; COLUMN

CHROMATOGRAPHY, ion exchange,

I have been a project leader responsible for development of cancer diagnostic affinity and HPLC; Electrophoresis (2 -D

gels, westerns, etc.)

reagents (anti-oncogene, anti-HTLV and cytokeratin antibodies and immuno-

histochemistry reagents); and I validated claims of reagents and coordinated

collaborations among independent research labs and the marketing group at

Triton Biosciences.

I have coordinated all phases of laboratory build-outs for three laboratories

(molecular biology, biochemistry and diagnostics); this included ordering all

laboratory equipment, hiring and training research assistants/associates;

mentoring of post-doctoral fellows and physicians; planning and implementing

budgets; and organizing a Mac computer network and developing databases for

them.

PROFESSIONAL ACTIVITIES:

Electronic Seminars Publication and Web site manager, UCSF (1992-2000)

Editing & layout for SouthEnder quarterly newsletter (2006-2008)

Member The Association for Research in Vision and Ophthalmology

file C /Users/Kathy/Documents/Web/KRB%20resume/KRB_resume_v6.html[6/12/2011 8:43:39 PM]

Kathy Bailey, Researcher-Resume

EMPLOYMENT

SPECIALIST, DIABETES CENTER, UCSF

March 2010-present

I developed a sensitive and economical assay and general method for

detection of compounds with known and unknown androgen activity and

conduct pilot studies employing the assay to measure said compounds in

athletes and patients undergoing hormone replacement therapy.

SPECIALIST, OPHTHALMOLOGY DEPARTMENT, UCSF

April 1996-present

I processed images acquired by Adaptive Optics Scaning Laser

Ophthalmoscopy

[AOSOLO] and maintained a database of images of subjects' retina images for

clinical studies. I have identified scavenger receptors and investigated gene

regulation by lipid & modified lipids, i.e. oxidized-lipid uptake in human retinal

epithelial cells; and have tested drugs which modulate the uptake. Lipid and

modified lipids were used to devolop assays that simulate photoreceptor outer

segment uptake. I also identified isoforms of thyroid hormone and RXR

receptors and other genes in the trabecular meshwork which may be involved

in modulating ocular pressure observed in glaucoma and retinal degeneration

by molecular, immunohistochemical and assay analysis.

CORE MANAGER - DEPT OF NEUROLOGY, GALLO CENTER, S.F.,

CA

1994-1996

The center studies the effect of alcohol on physiology, cell biology and genes. I

managed the core facility which performed automated sequencing projects and

oligonucleotide synthesis; and engineered and prepared constructs for

expression of fusion proteins.

RESEARCH ASSOCIATE, PHYSIOLOGY &

BIOCHEMISTRY/BIOPHYSICS, UCSF

1992-1994

The lab studies signaling in the retina and retinal cell lineages. I cloned cGMP

gated ion channels in rods and cones of striped bass and expressed the wild

type channels for physiological studies.

RESEARCH ASSOCIATE/LAB MANAGER, NEUROSURGERY/BRAIN

TUMOR RESEARCH CENTER, UCSF

1990-1991

The lab studied gene regulation in neural development, astrocyte function and

genetics. I investigated gene regulatory sequences in the adrenal medulla and

managed all aspects of the laboratory. Experimental proposals, journal clubs

and results were prepared and presented regularly.

RESEARCH ASSOCIATE/LAB MANAGER - PSYCHIATRY, UCSF

1986-1990

The lab focused on the characterization and function of lectins. I investigated

the role of endogenous lectins in vertebrate tissues and performed the

biochemistry and molecular biology required for the study. I managed the

administrative and operational aspects of the lab.

DIAGNOSTICS PROJECT LEADER - TRITON BIOSCIENCES, INC,

ALAMEDA, CA

1984-1986

Our group developed cancer diagnostics and clinical assays. I was project

leader for cancer diagnostics reagents. I collaborated with research and

file C /Users/Kathy/Documents/Web/KRB%20resume/KRB_resume_v6.html[6/12/2011 8:43:39 PM]

Kathy Bailey, Researcher-Resume

business teams to transfer and develop research reagents. I established and

wrote upprocedures and protocols for patents, clinical trials, quality control.

Reagents/assays included cytokeratin antibodies/assays, HTLV I

antibodies/assays, anti-oncogene and anti-TGF antibodies/assays.

RESEARCH ASSOCIATE/LAB MANAGER -

HEMATOLOGY/ONCOLOGY, UCLA

1982-1985

The lab was involved in investigating cancer diagnostics. I investigated

potential cancer diagnostics,i.e., oncogene protein assays (using RIPA and IEF

gels), performed RFLP's and TGF assays for Triton Biosciences, generated

and characterized anti-oncogene antibodies and generated oncogene

constructs for transfecting cells.

RESEARCH ASSOCIATE - IMMUNOLOGY & MICROBIOLOGY,

UCLA

1980-1982

I assisted in the development of immunological assays for patient studies,

performed immunofluorescence typing of lymphocytes, monitoring

immunological response by ADCC/SK, PHA, specific radioimmunoassay and B

cell plaque assay in a clinical laboratory setting. Isolated cells from patient

sample and monitored blood cell types and counts manually and with cell

sorting techniques.

PUBLICATIONS:

Ishida, BY, Keith G Duncan, Kathy R Bailey, John P Kane, and Daniel M

Schwartz, "High Density Lipoprotein - mediated lipid efflux from retinal

pigmented epithelial; Cells in Culture"; BJOPHTHALMOL/2005/08576.

Brian Y. Ishida, Kathy R. Bailey, Keith G. Duncan, Robert J. Chalkley, A.L.

Burlingame, John Kane, Daniel M. Schwartz, "Regulated Expression of

Apolipoprotein E by Human Retinal Pigment Epithelial Cells", Journal of

Lipid Research, 16 October.

Bailey, K.R., B.Y. Ishida, K.G. Duncan, J.P. Kane, D.M. Schwartz. 2003,

Apolipoprotein E Containing High Density Lipoproteins can Function as

Preferential Acceptors for Retinal Pigment Epithelium Cell Digested Photo

Receptor Outer Segment Lipids, Association for Research in Vision and

Ophthalmology (ARVO) Annual Meeting. Abstract #477.

Stewart, J.M., K.R. Bailey, K.G. Duncan, J.P. Kane, D.M. Schwartz. 2003.

Expression of Reverse Cholesterol Transport Proteins SR-B1, SR-BII and

ABCA1 in the Human Retinal Pigment Epithelium, Association for Research

in Vision and Ophthalmology (ARVO) Annual Meeting. Abstract #1711.

Keith G. Duncan, Kathy Bailey, John P. Kane and Daniel M. Schwartz,

Biochemical and Biophysical Research Communications (March 2001)

Keith G. Duncan, Michele D. Jumper, Ralff C.J. Ribeiro, Kathy R. Bailey, Paul

M. Yen, Akira Sugawara, Ashmi Patel, Robert Stern, William W. Chin John

D.Baxter and Daniel M. Schwartz, "Human Trabecular Meshwork Cells: A

Thyroid Hormone Target Tissue." Graefe's Archive of Clinical and

Experimental Ophthalmology 1999:237:231-240.

K.G. Duncan, K.R. Bailey, J.D. Baxter and D.M. Schwartz. "The Human

Retinal Pigment Epithelium: A Target Tissue for Thyroid Hormones."

Ophthalmic Research 1999:31:399-406.

PATENT(S):

(1) U.S. Patent Application No.: 10/313,641. TREATMENTS FOR AGE-

RELATED MACULAR DEGENERATION (AMD). Dec 6, 2002; (2) U.S. Patent

Application No.: U.S. Continuation-in-Part Patent Application No.: . METHODS

TO INCREASE REVERSE CHOLESTEROL TRANSPORT IN THE RETINAL

PIGMENT EPITHELIUM (RPE) AND BRUCH S MEMBRANE (BM), March 5,

2004; (3) Divisional Patent Application No. : . TREATMENT FOR DARK

ADAPTATION. February 9, 2005.

file C /Users/Kathy/Documents/Web/KRB%20resume/KRB_resume_v6.html[6/12/2011 8:43:39 PM]

Kathy Bailey, Researcher-Resume

1 November 2009

file C /Users/Kathy/Documents/Web/KRB%20resume/KRB_resume_v6.html[6/12/2011 8:43:39 PM]



Contact this candidate